3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
CNS
1
Conditions
Urinary Tract Infections
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Renal Insufficiency, Chronic
1
Pulmonary Arterial Hypertension
1
Pneumonia
1
Pain
1
Neutropenia
1
Neoplasm Metastasis
1
Migraine Disorders
1
Menorrhagia
1
Meningitis, Bacterial
1
Meningitis
1
Melanoma
1
Intraabdominal Infections
1
Influenza, Human
1
Inflammation
1
Infections
1
Hypokalemia
1
Hypertension
1
Hyperaldosteronism
1
Herpes Simplex
1
Hemophilia A
1
Hemangioma, Capillary
1
Interventions
pegfilgrastim
26
Filgrastim
24
Cyclophosphamide
8
Docetaxel
7
Etoposide
6
pegylated granulocyte colony-stimulating factor
5
Cytarabine
5
eflapegrastim
4
Granulocyte Colony-Stimulating Factor
4
Leucovorin
3
Fluorouracil
3
Doxorubicin
3
Cyclosporine
3
Cefepime
3
Caspofungin
3
Carboplatin
3
liposomal amphotericin B
2
Vincristine
2
Vancomycin
2
Topotecan
2
Methylprednisolone
2
Methotrexate
2
Itraconazole
2
Irinotecan
2
Ifosfamide
2
Idarubicin
2
Fluconazole
2
Daunorubicin
2
Cisplatin
2
Amikacin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neutropenia
×
Bosentan
×
Clear all
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled